A Multiomic Analysis to Identify Drivers of Subclinical Vascular Disease in Systemic Lupus Erythematosus
- PMID: 38923259
- DOI: 10.1002/art.42925
A Multiomic Analysis to Identify Drivers of Subclinical Vascular Disease in Systemic Lupus Erythematosus
Abstract
Objective: Systemic lupus erythematosus (SLE) increases cardiovascular disease (CVD) risk, and this is not explained by traditional risk factors. Characterization of blood immunologic signatures that associate with subclinical CVD and predict its progression has been challenging and may help identify subgroups at risk.
Methods: Patients with SLE (n = 77) and healthy controls (HCs) (n = 27) underwent assessments of arterial stiffness, vascular wall inflammation, and coronary atherosclerosis burden with cardio-ankle vascular index (CAVI); fluorodeoxyglucose-positron emission tomography/computed tomography (CT) (target-to-background ratio [TBR]); and coronary CT angiography. Whole blood bulk RNA sequencing was performed in a subset of study participants (HC n = 10, SLE n = 20). In a partially overlapping subset (HC n = 24, SLE n = 64), serum inflammatory protein biomarkers were quantified with an Olink platform.
Results: CAVI, TBR, and noncalcified coronary plaque burden (NCB) were increased in patients with SLE compared to HCs. When comparing patients with SLE with high CAVI scores to those with low CAVI scores or to HCs, there was a down-regulation of genes in pathways involved in the cell cycle and differentially regulated pathways related to metabolism. Distinct serum proteins associated with increased CAVI (CCL23, colony-stimulating factor 1, latency-activating peptide transforming growth factor β1, interleukin 33 [IL-33], CD8A, and IL-12B), NCB (monocyte chemotactic protein 4 and FMS-like tyrosine kinase 3 ligand [Flt3L]), and TBR (CD5, IL-1α, AXIN1, cystatin D [CST5], and tumor necrosis factor receptor superfamily 9; P < 0.05).
Conclusion: Blood gene expression patterns and serum proteins that associate with worse vascular phenotypes suggest dysregulated immune and metabolic pathways linked to premature CVD. Cytokines and chemokines identified in associations with arterial stiffness, inflammation, and NCB in SLE may allow for characterization of new CVD biomarkers in lupus.
Published 2024. This article is a U.S. Government work and is in the public domain in the USA. Arthritis & Rheumatology published by Wiley Periodicals LLC on behalf of American College of Rheumatology.
Similar articles
-
Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus.JCI Insight. 2018 Apr 19;3(8):e99276. doi: 10.1172/jci.insight.99276. eCollection 2018 Apr 19. JCI Insight. 2018. PMID: 29669944 Free PMC article. Clinical Trial.
-
Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.Lupus. 2018 Aug;27(9):1509-1516. doi: 10.1177/0961203318782424. Epub 2018 Jun 28. Lupus. 2018. PMID: 29954279
-
The relationship between cardio-ankle vascular index and subclinical atherosclerosis evaluated by cardiac computed tomographic angiography.Clin Cardiol. 2017 Aug;40(8):549-553. doi: 10.1002/clc.22695. Epub 2017 Mar 8. Clin Cardiol. 2017. PMID: 28272814 Free PMC article.
-
Mechanistic insight into premature atherosclerosis and cardiovascular complications in systemic lupus erythematosus.J Autoimmun. 2022 Oct;132:102863. doi: 10.1016/j.jaut.2022.102863. Epub 2022 Jul 16. J Autoimmun. 2022. PMID: 35853760 Review.
-
Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention.Inflammation. 2021 Oct;44(5):1663-1682. doi: 10.1007/s10753-021-01455-6. Epub 2021 Apr 5. Inflammation. 2021. PMID: 33821395 Review.
References
REFERENCES
-
- Thomas G, Mancini J, Jourde‐Chiche N, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiple‐cause‐of‐death analysis. Arthritis Rheumatol 2014;66(9):2503–2511.
-
- Oliveira CB, Kaplan MJ. Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus. Semin Immunopathol 2022;44(3):309–324.
-
- Manzi S, Selzer F, Sutton‐Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 1999;42(1):51–60.
-
- Carlucci PM, Purmalek MM, Dey AK, et al. Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus. JCI Insight 2018;3(8):e99276.
-
- Björnådal L, Yin L, Granath F, et al. Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964‐95. J Rheumatol 2004;31(4):713–719.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous